We observed subtype-specific strategies in managing X chromosome dosage: seminomas maintain constitutive XIST expression and epigenetic silencing, leading to increased replication stress, whereas non-seminomas modulate XIST based on chromosome copy number and show greater epigenetic plasticity, reflecting their more differentiated state. The gene discussed is XIST; the disease is seminoma.